Cargando…
Incidence and risk of fatigue in cancer patients treated with MET inhibitors: A systematic review and meta-analysis
BACKGROUND: The N-methyl-N′-nitroso-guanidine human osteosarcoma transforming gene (MET) inhibitors show a surprising survival benefit in the treatment of numerous tumors especially in MET-high tumor. Besides their impressive efficacy, fatigue reduced by MET inhibitors is still the safety issue duri...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709275/ https://www.ncbi.nlm.nih.gov/pubmed/31145273 http://dx.doi.org/10.1097/MD.0000000000015522 |